Tag: Multiple Myeloma
Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma
Drug combination approved to treat patients who have failed at least five other treatments
Cardiovascular AEs Common With Carfilzomib in Multiple Myeloma
Patients with relapsed multiple myeloma experiencing CVAEs had inferior survival
Recommendations Issued for Imaging Use in Multiple Myeloma
Low-dose whole-body CT recommended over conventional skeletal survey for detection of bone disease
Gait Speed Is Prognostic in Older Patients With Blood Cancer
Decrease in gait speed linked to higher mortality, increased odds of unplanned hospitalization, ED use
Daratumumab Cuts Risk for Progression in Multiple Myeloma
Adding daratumumab to lenalidomide + dexamethasone beneficial for newly diagnosed multiple myeloma
FDA: Higher Risk for Death Found With Venclexta in Multiple Myeloma
Enrollment suspended for trials investigating Venclexta for treatment of multiple myeloma
Recommendations Issued for HSCT in Multiple Myeloma
Autologous stem cell transplant remains essential component of MM therapy in eligible patients
Model Predicts Survival in Transplant-Ineligible Myeloma Patients
U.K. Myeloma Research Alliance Risk Profile predicts overall survival based on data from two trials
HRQoL Scores Decrease With Treatment Line in Multiple Myeloma
Relatively high scores seen for patients with multiple myeloma in first treatment-free interval
Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
In phase 2 trial, longer progression-free survival for elotuzumab with pomalidomide and dexamethasone
